- Report
- April 2025
- 44 Pages
United States
- Report
- December 2025
- 218 Pages
Global
From €4307EUR$4,799USD£3,757GBP
- Report
- August 2025
- 154 Pages
Global
From €2378EUR$2,650USD£2,075GBP
- Report
- June 2025
- 379 Pages
Global
From €4442EUR$4,950USD£3,875GBP
- Report
- June 2025
- 151 Pages
Global
From €3141EUR$3,500USD£2,740GBP
- Report
- January 2026
- 187 Pages
Global
From €4173EUR$4,650USD£3,640GBP
- Report
- April 2025
- 100 Pages
Global
From €5340EUR$5,950USD£4,658GBP
- Report
- August 2025
- 200 Pages
Global
From €2235EUR$2,490USD£1,949GBP
- Report
- May 2025
- 200 Pages
Global
From €2235EUR$2,490USD£1,949GBP
- Report
- May 2025
- 200 Pages
Global
From €2235EUR$2,490USD£1,949GBP
- Report
- January 2026
- 188 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 198 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 191 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 184 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 196 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 185 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 182 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 190 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 190 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 194 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more